Back
Royalty Pharma PLC Stock Price Chart
Sponsored
RPRX
Sponsored
FREE REPORT: 2025 Gold Price Outlook
Get Your Copy of "2025 Gold Forecast: A Perfect Storm for Demand" Here.
Sell
32
RPRX
Royalty Pharma PLC
Last Price:
$24.97
Seasonality Move:
1.44%
7 Day Trial
ALL ACCESS PASS
$
7
Trump's Legacy-Defining Momentor Strike
But the Surprising Way Trump Solves it Could Cement His Legacy.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RPRX is experiencing buying pressure, which is a positive indicator for future bullish movement.
Royalty Pharma PLC Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 24.88 | Buy |
20-day SMA: | 25.71 | Sell |
50-day SMA: | 26.45 | Sell |
200-day SMA: | 27.59 | Sell |
8-day EMA: | 24.95 | Sell |
20-day EMA: | 25.48 | Sell |
50-day EMA: | 26.23 | Sell |
200-day EMA: | 27.55 | Sell |
Royalty Pharma PLC Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.52 | Sell |
Relative Strength Index (14 RSI): | 39.23 | Sell |
Chaikin Money Flow: | 5676845 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (25.09 - 26.47) | Sell |
Bollinger Bands (100): | (26.05 - 28.27) | Sell |
Royalty Pharma PLC Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Royalty Pharma PLC Stock
Is Royalty Pharma PLC Stock a Buy?
-
Royalty Pharma PLC share price is 24.94 while RPRX 8-day simple moving average is 24.88, which is a Buy signal.
-
The stock price of RPRX is 24.94 while Royalty Pharma PLC 20-day SMA is 25.71, which makes it a Sell.
-
Royalty Pharma PLC 50-day simple moving average is 26.45 while RPRX share price is 24.94, making it a Sell technically.
-
RPRX stock price is 24.94 and Royalty Pharma PLC 200-day simple moving average is 27.59, creating a Sell signal.
RPRX Technical Analysis vs Fundamental Analysis
Sell
32
Royalty Pharma PLC (RPRX)
is a Sell
Is Royalty Pharma PLC a Buy or a Sell?
-
Royalty Pharma PLC stock is rated a SellThe current Royalty Pharma PLC [RPRX] share price is $24.94. The Score for RPRX is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
Royalty Pharma PLC Stock Info
Market Cap:
11.1B
Price in USD:
24.94
Share Volume:
6.9M
Royalty Pharma PLC 52-Week Range
52-Week High:
31.66
52-Week Low:
24.05
Sell
32
Royalty Pharma PLC (RPRX)
is a Sell
Royalty Pharma PLC Share Price Forecast
-
What is the Royalty Pharma PLC stock price today?The Royalty Pharma PLC stock price is 24.94 USD today.
-
Will RPRX stock go up or go down?Royalty Pharma PLC> share price is forecast to RISE/FALL based on technical indicators
-
Is Royalty Pharma PLC overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Royalty Pharma PLC is overvalued.
Is Royalty Pharma PLC Stock a Buy?
-
Royalty Pharma PLC share price is 24.94 while RPRX 8-day exponential moving average is 24.95, which is a Sell signal.
-
The stock price of RPRX is 24.94 while Royalty Pharma PLC 20-day EMA is 25.48, which makes it a Sell.
-
Royalty Pharma PLC 50-day exponential moving average is 26.23 while RPRX share price is 24.94, making it a Sell technically.
-
RPRX stock price is 24.94 and Royalty Pharma PLC 200-day simple moving average is 27.55, creating a Sell signal.
Fundamental Analysis of Royalty Pharma PLC
Is Royalty Pharma PLC a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.24 per share, and an increase next year of $0.22 per share.
Technical Analysis of Royalty Pharma PLC
Should I short Royalty Pharma PLC stock?
-
RPRX Moving Average Covergence Divergence (MACD) indicator is -0.52, suggesting Royalty Pharma PLC is a Sell
-
Royalty Pharma PLC Relative Strength Index (RSI) is 39.23, which suggest Royalty Pharma PLC is oversold
-
The Bollinger Bands (25) for Royalty Pharma PLC is (25.09 - 26.47), which suggest Royalty Pharma PLC is a Sell
-
The Bollinger Bands (100) for Royalty Pharma PLC is (26.05 - 28.27), which suggest Royalty Pharma PLC is a Sell
* Royalty Pharma PLC stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.